These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12018014)

  • 1. Findings and accomplishments of ATSDR's Superfund-mandated Substance-Specific Applied Research Program.
    Stevens YW; Williams-Johnson MM; De Rosa CT; Cibulas W
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):29-39. PubMed ID: 12018014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Great lakes research--important human health findings and their impact on ATSDR's Superfund research program.
    Hicks HE; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):49-61. PubMed ID: 12018016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future directions of environmental public health research: ATSDR's 2002-2010 agenda for six priority focus areas.
    Spengler RF; Falk H
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):77-83. PubMed ID: 12018019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of chemical mixtures in public health practice.
    de Rosa CT; El-Masri HA; Pohl H; Cibulas W; Mumtaz MM
    J Toxicol Environ Health B Crit Rev; 2004; 7(5):339-50. PubMed ID: 15371239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATSDR's information databases to support human health risk assessment of hazardous substances. Agency for Toxic Substances and Disease Registry.
    Johnson BL
    Toxicol Lett; 1995 Sep; 79(1-3):11-6. PubMed ID: 7570647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emergency response program at the Agency for Toxic Substances and Disease Registry.
    Holler J
    J Environ Health; 2013 Oct; 76(3):46-7. PubMed ID: 24288850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agency for Toxic Substances and Disease Registry Brownfields/ land-reuse site tool.
    Perlman GD; Berman L; Leann K; Bing L
    J Environ Health; 2012 Dec; 75(5):30-4. PubMed ID: 23270111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superfund research program--accomplishments and future opportunities.
    Au WW; Falk H
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):165-8. PubMed ID: 12018012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating a Biorepository Into the National Amyotrophic Lateral Sclerosis Registry.
    Horton DK; Kaye W; Wagner L
    J Environ Health; 2016 Nov; 79(4):38-40. PubMed ID: 28935999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer policy framework for: public health assessment of carcinogens in the environment.
    DeRosa CT; Stevens YW; Johnson BL
    Toxicol Ind Health; 1993; 9(4):559-75. PubMed ID: 8296311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Superfund Basic Research Program--making a difference: past, present, and future.
    Anderson B; Thompson C; Suk WA
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):137-41. PubMed ID: 12018007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaboration and importance of federally sponsored Superfund research programs.
    Spengler RF; Anderson BE; Zenick H
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):1-9. PubMed ID: 12018001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATSDR evaluation of health effects of chemicals. VI. Di(2-ethylhexyl)phthalate. Agency for Toxic Substances and Disease Registry.
    Fay M; Donohue JM; De Rosa C
    Toxicol Ind Health; 1999 Dec; 15(8):651-746. PubMed ID: 10786378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving with the times, the new national toxic substance incidents program.
    Duncan MA; Orr MF
    J Med Toxicol; 2010 Dec; 6(4):461-3. PubMed ID: 20838954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a priority list of chemical mixtures occurring at 1188 hazardous waste sites, using the HazDat database.
    Fay RM; Mumtaz MM
    Food Chem Toxicol; 1996; 34(11-12):1163-5. PubMed ID: 9119332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH; Pohl HR
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agency for Toxic Substances and Disease Registry's 1997 priority list of hazardous substances. Latent effects--carcinogenesis, neurotoxicology, and developmental deficits in humans and animals.
    Ostrowski SR; Wilbur S; Chou CH; Pohl HR; Stevens YW; Allred PM; Roney N; Fay M; Tylenda CA
    Toxicol Ind Health; 1999 Nov; 15(7):602-44. PubMed ID: 10677885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergies between veterinarians and para-professionals in the public and private sectors: organisational and institutional relationships that facilitate the process of privatising animal health services in developing countries.
    Woodford JD
    Rev Sci Tech; 2004 Apr; 23(1):115-35; discussion 391-401. PubMed ID: 15200091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating toxicologic end points to derive minimal risk levels for hazardous substances.
    Chou CH; Williams M; Jones D; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):71-5. PubMed ID: 12018018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health effects classification and its role in the derivation of minimal risk levels: hepatic effects.
    Pohl HR; Chou CH
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):161-71. PubMed ID: 15869832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.